Palak Gosalia
Sanford Burnham Prebys Medical Discovery Institute(US)Discovery Institute(US)
Publications by Year
Research Areas
Analytical Chemistry and Chromatography, Neuropeptides and Animal Physiology, Pharmacological Receptor Mechanisms and Effects, Receptor Mechanisms and Signaling, Analytical Chemistry and Sensors
Most-Cited Works
- → Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor(2012)62 cited
- → Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy(2012)56 cited
- → Discovery of ML314, a Brain Penetrant Nonpeptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor(2013)48 cited
- → Discovery of a Plasmodium falciparum Glucose-6-phosphate Dehydrogenase 6-phosphogluconolactonase Inhibitor ( R , Z )- N -((1-Ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2 H -benzo[ b ][1,4]thiazine-6-carboxamide (ML276) That Reduces Parasite Growth in Vitro(2012)38 cited
- → Discovery of Sulfonamidebenzamides as Selective Apoptotic CHOP Pathway Activators of the Unfolded Protein Response(2014)20 cited
- → An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-Phosphogluconolactonase(2022)18 cited
- → Imidazole-derived agonists for the neurotensin 1 receptor(2013)17 cited
- Functional antagonists of the Apelin (APJ) receptor(2013)
- → Development of a Robust High-Throughput Screening Platform for Inhibitors of the Striatal-Enriched Tyrosine Phosphatase (STEP)(2021)14 cited
- → Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells(2021)11 cited